Table 1 Clinical characteristics and baseline demographic of 160 RA patients
Age, yrs | 56.2 ± 12.4 |
|---|---|
Female, n (%) | 117 (72.2) |
Duration of RA, yrs | 7 (4–14) |
RF-positivity, n (%) | 132 (81.5) |
Current smoking, n (%) | 39 (24.1) |
Hypertension, n (%) | 90 (61.2) |
Diabetes mellitus, n (%) | 9 (5.6) |
CVD comorbidity, n (%) | 46 (28.4) |
Statin use, n (%) | 6 (3.7) |
BMI, kg/m2 | 25.2 ± 4.6 |
DAS28 | 5.7 ± 1.0 |
HAQ-score | 1.3 ± 0.6 |
MTX use, n (%) | 126 (77.8) |
GC use, n (%) | 54 (33.3) |
GC, mg/day | 5 (5 to 7.5) |
NSAID use, n (%) | 112 (69.1) |